17/2 mg/ml tirzepatide Empower dosage chart: complete guide to every concentration and dose Is this a normal dose

Zou H, Zhang C, Ni J, Han X

A positive CVOT readout is what unlocks a broad cardiovascular-risk-reduction claim on the eventual label, analogous to what LEADER did for liraglutide and SELECT did for semaglutide

PMID: 36942050 Acta Biochim Biophys Sin (Shanghai) 2021 Mar 2;53(3):333-341

All eligible respondents also confirmed their willingness to participate, and gave explicit informed consent to participate in the survey, and for their demographic data and preference data to be captured and stored for research purposes, and reported in an anonymized manner

doi: 10.1016/j.freeradbiomed.2007.02.031

first, dilution of the viral copy number decreases sensitivity